January 6, 2010 — Welcome back lithium. After losing its luster because of concerns over potentially serious adverse effects, this drug is drawing increasing respect. Results from the Bipolar ...
For people with bipolar I disorder*, for whom long-term therapy is clinically indicated, both combination therapy with lithium plus valproate and lithium monotherapy are more likely to prevent relapse ...
The European Medicines Agency’s (EMA) safety committee (PRAC) is recommending precautionary measures for the treatment of male patients with valproate medicines. These measures are to address a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results